Evolva Holding SA (EVE)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 2.400 |
|---|---|
| 52-week range | 0.750 – 2.740 |
| Return, 1 month / 3 months | +17.6% / +10.1% |
| Return, 1 year / 3 years | +178.4% / −20.0% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 86.9% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 0.08M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Evolva Holding SA is a Swiss company that makes specialty ingredients using fermentation and synthetic biology rather than traditional chemical extraction. Its portfolio includes flavour and fragrance ingredients such as vanillin and nootkatone, along with health and nutrition ingredients like resveratrol. The company serves customers in the food, beverage, flavour, fragrance and consumer health industries, and it is based in Reinach, Switzerland.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code EVE, and the price on this page is in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Evolva Holding SA (EVE) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 2.400 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 83 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 178.4% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 53.4% | ||
| From 52-week high | -11.8% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | 140.5% | ||
| 12-month return, skipping the last month | 136.7% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 86.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +17.6% |
| 3 months | +10.1% |
| 6 months | +140.5% |
| 1 year | +178.4% |
| 3 years | −20.0% |
| 5 years | −93.0% |
Signals
| 50-day / 200-day average | 2.272 / 1.564 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.100 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.